Management of Nystagmus Following Diphenhydramine Overdose
Nystagmus after diphenhydramine overdose is a self-limited anticholinergic manifestation that requires supportive care only—no specific pharmacologic treatment exists for this symptom, and management focuses on airway protection, monitoring for life-threatening complications (seizures, cardiac conduction abnormalities), and allowing the drug to clear naturally. 1, 2
Clinical Context and Symptom Profile
Nystagmus is a highly characteristic finding in diphenhydramine toxicity and appears alongside other anticholinergic signs:
Nystagmus occurs commonly in diphenhydramine overdose as part of the anticholinergic toxidrome, typically accompanied by mydriasis, tachycardia, altered mental status, warm/dry/flushed skin, and urinary retention. 1, 3
The symptom is self-limited and resolves as diphenhydramine is metabolized and eliminated; no specific antidote or treatment targets nystagmus itself. 1, 2
Diplopia may coexist with nystagmus in diphenhydramine poisoning, further contributing to visual disturbance. 1
Immediate Priorities: Life-Threatening Complications
Your primary focus should be on complications that cause morbidity and mortality, not the nystagmus itself:
Airway Protection
Secure the airway immediately via endotracheal intubation if the patient has lost protective reflexes (absent gag/cough), cannot maintain airway patency, or has declining mental status—this prevents aspiration, which is the critical mechanism of harm in massive CNS depressant overdoses. 4
Pre-intubation preparation should include 100% oxygen, cricoid pressure (10 N awake, 30 N after loss of consciousness), suctioning of secretions, and head-elevated positioning when hemodynamically stable. 4
If intubation is delayed, place the patient in lateral decubitus position to allow secretion drainage, use jaw-thrust/chin-lift maneuvers, provide bag-mask ventilation with 100% oxygen, and insert oropharyngeal/nasopharyngeal airways as tolerated. 4
Cardiac Monitoring and Sodium Channel Blockade
Obtain serial ECGs immediately to assess for QRS prolongation (>100 ms) and terminal R wave in aVR, which indicate sodium channel blockade—a potentially lethal complication of diphenhydramine overdose. 3, 2
Administer intravenous sodium bicarbonate (1–2 mEq/kg bolus) if QRS widening is present, as this effectively reverses sodium channel blockade and prevents wide-complex dysrhythmias. 3, 2
Continue cardiac monitoring for supraventricular and ventricular dysrhythmias throughout the observation period. 2
Seizure Management
Administer benzodiazepines (lorazepam 2–4 mg IV or diazepam 5–10 mg IV) if seizures occur, as diphenhydramine can precipitate tonic-clonic seizures. 3, 2
Do not use physostigmine in the out-of-hospital or emergency setting for diphenhydramine overdose; it should be reserved for in-hospital administration only and is not indicated for nystagmus. 2
Observation and Disposition
Observe asymptomatic patients for at least 4 hours post-ingestion before considering discharge; if nystagmus or other symptoms are present, extend observation until clinical improvement is documented. 2
Refer to the emergency department any patient with suicidal intent, intentional abuse, suspected malicious intent, or any moderate-to-severe symptoms (agitation, hallucinations, abnormal muscle movements, loss of consciousness, seizures, respiratory depression). 2
Children <6 years who ingest ≥7.5 mg/kg and patients ≥6 years who ingest ≥7.5 mg/kg or ≥300 mg (whichever is less) should be referred to an emergency department regardless of symptoms. 2
What NOT to Do
Do not administer activated charcoal outside the hospital setting, as diphenhydramine can cause rapid loss of consciousness or seizures, creating aspiration risk. 2
Do not induce emesis following diphenhydramine ingestion. 2
Do not attempt pharmacologic treatment of nystagmus itself—agents used for chronic nystagmus (gabapentin, memantine, 4-aminopyridine, clonazepam) are intended for congenital or acquired neurologic nystagmus, not acute drug-induced nystagmus, and have no role in diphenhydramine overdose management. 5, 6
Do not use flumazenil if benzodiazepine co-ingestion is suspected, as it is contraindicated in mixed overdoses and offers no benefit for diphenhydramine toxicity. 7, 4, 8
Monitoring for Complications Beyond Nystagmus
Assess for rhabdomyolysis in patients with prolonged immobility, agitation, or seizures by checking creatine kinase and renal function; diphenhydramine overdose can cause widespread skeletal muscle breakdown. 9
Monitor for urinary retention, a common anticholinergic effect that may require bladder catheterization. 1, 10
Recognize that respiratory insufficiency can occur in severe overdoses and may necessitate mechanical ventilation. 1
Expected Clinical Course
Most diphenhydramine intoxications have an uncomplicated course with supportive care alone; symptoms including nystagmus resolve as the drug is eliminated. 1
Impaired consciousness and psychotic behavior (often resembling catatonic stupor with anxiety) are highly specific for diphenhydramine poisoning and should prompt consideration of this diagnosis. 1
Diphenhydramine plasma levels range widely (0.1–4.7 μg/mL) depending on dose and time since ingestion, but levels do not guide acute management—treat the patient, not the number. 1